Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Bank Bradesco Insider Denise Pauli Pavarina Buys $843K of Stock
Denise Pauli Pavarina bought 46,874 shares of Bank Bradesco at $17.98 a share, worth $843K in total on Sep 18, 2026. Shares held after the trade: 412,864 (+12.8%).
LandBridge Company LLC's subsidiary, DBR Land Holdings LLC, has launched a private placement offering of $100 million in additional 6.250% Senior Notes due 2030. The proceeds from the offering are intended to be used to repay a portion of the outstanding borrowings under the company's revolving credit facility.
i-80 Gold Corp. announced a positive feasibility study for its Granite Creek Underground project in Nevada, reporting an initial mineral reserve of 556,500 ounces of gold and an after-tax NPV of $118 million. The company also released initial assay results from its Mineral Point open pit project, including a step-out hole showing 1.33 g/t Au over 225.6 meters. These updates support the company's strategy to feed its Lone Tree processing plant, which is expected to be operational by late 2027.
GE Aerospace announced that its Board of Directors has appointed Wesley Bush as the new independent Lead Director, succeeding Tom Horton who has served in the role since 2018. Additionally, the company reported that Judson Althoff, who joined the Board in June 2024, has been appointed to the Audit Committee.
RTB Digital (Roundtable) issued a 2027 operating forecast projecting $102.1 million in revenue and $13.2 million in Adjusted EBITDA. The forecast assumes the successful closure and integration of the Paradium.AI partnership and represents the company's first full year of at-scale platform operations.
Solaris Energy Infrastructure, LLC, a subsidiary of Solaris Energy Infrastructure, Inc., announced a private placement offering of $1.0 billion in Senior Notes due 2032. The company intends to use the net proceeds for general corporate purposes, growth capital expenditures, and related fees and expenses.
SCYNEXIS appointed Steven K. Burke, M.D., to its Board of Directors and the Nominating and Corporate Governance Committee. Dr. Burke will receive an annual cash retainer of $45,000 plus $5,000 for committee service, along with initial equity grants of 5,750 stock options and 5,750 restricted stock units. The appointment adds deep nephrology drug development expertise as the company prepares to advance its ADPKD candidate, SCY-770, into Phase 2 trials.
PDS Biotechnology announced the publication of Phase 2 VERSATILE-002 trial results in JAMA Oncology, evaluating PDS0101 in combination with pembrolizumab for HPV16-positive head and neck cancer. The study reported a median overall survival of 39.3 months in ICI-naïve patients, significantly exceeding the 17.9 months typically seen with standard-of-care pembrolizumab. The treatment was well-tolerated with a 13.8% rate of Grade 3 or higher treatment-related adverse events.
MasterCraft Boat Holdings Director Peter G. Leemputte Buys $25K of Stock
Peter G. Leemputte, Director, bought 1,265 shares of MasterCraft Boat Holdings, Inc. at $19.73 a share, worth $25K in total on Sep 18, 2026. Shares held after the trade: 38,132 (+3.4%).
The FDA has lifted a full clinical hold on Filana Therapeutics' IND application for simufilam, allowing the company to proceed with a Phase 2a proof-of-concept study in TSC-related epilepsy. The company expects to begin patient screening by Q1 2027 and has already completed trial-readiness activities including site identification and drug supply preparation.
Contango Silver & Gold Inc. announced the completion of an updated Technical Report Summary (TRS) and Mineral Resource Estimate for its Kitsault Valley Project. The report, effective September 11, 2026, provides updated data on indicated and inferred mineral resources to support continued evaluation of potential underground extraction at the site.
Knightscope reported approximately $27 million in estimated renewals, bookings, and client awards across 109 contracts and seven vertical markets. The total includes a $17 million estimated three-year master services agreement with a multinational industrial client and a $5.8 million award from a national retailer. The update follows the company's launch of its 'Autonomous Security Force' at the GSX 2026 conference.
Affiliates of Blackstone, the majority owners of Jersey Mike's Subs Inc., entered into margin loan agreements for aggregate borrowings of approximately $1.09 billion. To secure the loans, Blackstone pledged 172,621,820 total shares and units, representing approximately 54.3% of the company's outstanding stock. While Jersey Mike's is not a party to the debt, a default by Blackstone could result in a foreclosure on the pledged collateral and a subsequent change in control of the company.
Adam L. Rosman resigned as Chief Administrative Officer and Chief Legal Officer of Fiserv, Inc., effective September 30, 2026. Eric C. Nelson, the company's current General Counsel and Secretary, will succeed him as Chief Legal Officer on October 1, 2026.
Duos Technologies Group Insider James Craig Nixon Buys $49.3K of Stock
James Craig Nixon bought 5,764 shares of Duos Technologies Group, Inc. at $8.50 to $8.60 a share (average $8.55) in 2 transactions, worth $49.3K in total on Sep 18, 2026. Shares held after the trade: 84,523 (+3.6%).
Iron Horse Acquisition II Signs $250M M&A Deal with Electra Vehicles, Inc.
Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending merger with Electra Vehicles, Inc., a transaction valued at over $250 million. The update highlights commercial milestones achieved since the April 2026 agreement, including new partnerships with Mooving, Omega Seiki Mobility, and Propel Industries, as the companies work toward a closing in the second half of 2026.
Blackstone Private Credit Fund declared monthly distributions for September 2026 of $0.1800 per share for Class I, S, and D common shares, payable to shareholders of record as of September 30, 2026. The fund also reported an aggregate net asset value (NAV) of approximately $43.2 billion and a total investment portfolio fair value of $76.4 billion as of August 31, 2026.
Or Offer, CEO, sold 69,700 shares of Similarweb Ltd. at $8.25 to $8.40 a share (average $8.32) in 2 transactions, worth $580K in total between Sep 18, 2026 and Sep 21, 2026. Shares held after the trade: 4,107,681 (-0.8%).
Beam Global M&A Deal with Unnamed European drone technology company
Beam Global has signed a non-binding letter of intent to acquire a European drone technology company that develops AI-enhanced software and hardware. If completed, Beam intends to manufacture the target's U.S. Department of War conditionally approved drone systems in its existing U.S. and European factories. The deal aims to transform Beam into a vertically integrated drone and software provider, leveraging its existing battery manufacturing expertise and government customer base.
Greenbrier Companies Wins $600M Contract from Saudi Railway Company
Greenbrier Companies announced orders for 3,400 new railcars valued at approximately $600 million during its fiscal fourth quarter. The orders include 780 units for the Saudi Railway Company (SAR), marking Greenbrier's first sale of intermodal units to SAR and expanding their long-term infrastructure partnership in Saudi Arabia.
Village Farms International CEO Michael A. Degiglio Buys $101K of Stock
Michael A. Degiglio, CEO, bought 35,000 shares of Village Farms International, Inc. at $2.89 a share, worth $101K in total on Sep 22, 2026. Shares held after the trade: 9,730,775 (+0.4%).
Group 1 Automotive has appointed Benjamin Hart, an analyst at major shareholder Conifer Management, to its Board of Directors, effective November 1, 2026. The appointment is part of a stockholder agreement that includes customary standstill and voting provisions, requiring Conifer to vote in favor of Board recommendations. In connection with the appointment, the Board will expand from ten to eleven members.
Willis Lease Finance Corporation entered into a purchase agreement to issue 1,750,000 shares of newly issued 8.09% Series B Preferred Stock to the Development Bank of Japan Inc. in a private placement. The transaction is expected to generate gross proceeds of approximately $35 million to support the company's global aviation services platform and business growth.
Lexeo Therapeutics Signs $8.3M M&A Deal with Mantle Therapeutics Inc.
Lexeo Therapeutics entered into a definitive agreement to acquire Mantle Therapeutics for an upfront purchase price of $5.3 million in cash and $3.0 million in common stock. The deal includes up to $12.0 million in contingent development and regulatory milestone payments plus a $1.0 million cash payment upon specific events, aimed at expanding Lexeo's Friedreich ataxia (FA) pipeline with new CNS-targeted modalities.
Celldex reported positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab in chronic spontaneous urticaria (CSU), meeting the primary and all key secondary endpoints. The data showed rapid and sustained efficacy through 24 weeks, including in patients refractory to omalizumab, with a favorable safety profile. The company plans to submit a Biologics License Application (BLA) to the FDA in 2027.
Earnings call
Sep 22, 2026, 8:00 AM ET
“The results from our two Phase 3 EMBARQ-CSU trials showed efficacy that is best-in-disease in CSU. We believe barzolvolimab is well-positioned to address large CSU populations of high unmet need—as a first-line therapy for patients with severe CSU or angioedema, and as the second-line advanced therapy of choice.”
Anthony Marucci, Co-Founder, President, and Chief Executive Officer at Celldex
“Barzolvolimab continued to show unprecedented complete response rates across the overall studies and demonstrated strong differentiation in patient populations underserved by existing therapies, including those with severe disease or angioedema, and those whose disease is refractory to omalizumab.”
Diane Young, MD, Senior Vice President and Chief Medical Officer of Celldex
Ligand Pharmaceuticals Signs $23M M&A Deal with Sydnexis, Inc.
Ligand Pharmaceuticals acquired royalty and milestone payment rights for Ryjunea from Sydnexis for $23 million upfront. Ryjunea is a treatment for pediatric myopia licensed to Santen Pharmaceutical in the EMEA region, where it is already approved. Ligand will receive tiered royalties ranging from low-double-digits to high-teens on net sales in those territories.
Viking Therapeutics announced positive topline results from a maintenance study of its GLP-1/GIP agonist VK2735, demonstrating that less frequent dosing (monthly and every other week) effectively maintained weight loss. Subjects receiving weekly 17.5 mg doses achieved 22% placebo-adjusted weight loss at Week 33, and the drug showed excellent tolerability with GI adverse event rates similar to placebo during the maintenance phase.
Earnings call
Sep 29, 2026, 8:00 AM ET
“The results of our innovative maintenance dosing study continue to demonstrate the significance of VK2735’s unique and differentiated half-life and PK profile, which appear to enable an effective new approach to achieving and maintaining the weight loss goals of patients living with obesity.”
Brian Lian, Ph.D., chief executive officer of Viking
“We believe this dose-ranging study clearly demonstrated the potential viability of novel, extended dosing approaches for maintenance following induction with an incretin-based therapy.”
Brian Lian, Ph.D., chief executive officer of Viking
Tonix Pharmaceuticals announced a new agreement with a major pharmacy benefit manager to provide coverage for TONMYA to approximately 21 million Medicare Part D beneficiaries. This expansion brings the total commercial and government payer coverage for the fibromyalgia treatment to approximately 166 million individuals, or 53% of the total U.S. population.
Cypherpunk Technologies appointed Amanda Fabiano, a veteran digital asset mining executive, to its Board of Directors as a Class III director. Mrs. Fabiano will receive an initial grant of 150,000 RSUs and an annual grant of 100,000 RSUs as part of her compensation package. The appointment coincides with the company's operational launch of its Zcash mining fleet, which recently generated over 3,000 ZEC for its treasury.
MillerKnoll reported Q1 fiscal 2027 net sales of $923.4 million, a 3.4% decrease year-over-year, while diluted EPS rose 31% to $0.38. Results were bolstered by a $10 million net benefit from U.S. government tariff refunds, which contributed $0.11 to diluted EPS and improved operating margins by 110 basis points.
Term
Q1 2027
Earnings call
Sep 22, 2026, 8:30 AM ET
“We delivered strong first quarter earnings, above expectations, reflecting solid execution across the enterprise. Despite softer than expected demand patterns in the quarter, we remain confident in our earnings outlook for the second quarter and full fiscal year. We are directing our efforts toward three key areas: focused priority setting, disciplined cost management, and strengthening our balance sheet for long-term value creation. Our results this quarter reflect the early impact of this work, and we expect this progress to continue”